SMTL ID : 8r7g.3 (3 other biounits)

Crystal structure of the kinase domain of ACVR1 (ALK2) with M4K2234

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.09 Å

Oligo State

monomer

Ligands

1 x YEE: 2-fluoranyl-6-methoxy-4-[4-methyl-5-[4-(4-propan-2-ylpiperazin-1-yl)phenyl]pyridin-3-yl]benzamide(Non-covalent)

YEE.1: 17 residues within 4Å: Chain A: V.16, V.24, A.35, K.37, E.50, L.65, L.83, T.85, H.86, Y.87, H.88, G.91, S.92, D.95, L.145, A.155, D.156 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.16, A:V.16, A:V.24, A:A.35, A:L.65, A:Y.87, A:L.145 Hydrogen bonds: A:T.85, A:H.88, A:D.156, A:D.156 Salt bridges: A:D.95

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ensan, D. et al., Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma. J.Med.Chem. (2020)

Release Date

2024-04-03

Peptides

Activin receptor type I: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Activin receptor type I

Related Entries With Identical Sequence